Serum KL-6 is specifically elevated in a majority of patients with interstitial lung diseases (ILDs), and this phenomenon is considered to reflect the production by regenerating type II epithelial cells based on disease activity [6-13]. This evidence concerns the gene MUC1 and interstitial lung disease.